Effective surgical adjuvant therapy for high-risk rectal carcinoma.
about
Statins for preventing colorectal adenoma and carcinomaPostoperative adjuvant chemotherapy in rectal cancer operated for cureConcomitant hyperthermia and radiation therapy for treating locally advanced rectal cancerUrsodeoxycholic acid for the prevention of colorectal adenomas and carcinomasGUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patientsThymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapyAdjuvant chemotherapy for rectal cancer: Is it needed?Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancerReview of systemic therapies for locally advanced and metastatic rectal cancerThe role of total mesorectal excision in the management of rectal cancerPast, present, and future of radiotherapy for the benefit of patientsPreoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectumAdjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and IIINeoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experiencePharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and RadiationInduction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors.Endorectal ultrasound: its role in the diagnosis and treatment of rectal cancer.Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials.Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic rectal cancer: a patterns of care study from the national cancer data base.UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review.Local Excision vs. Radical Resection in T1-2 Rectal Carcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data.Revised TN categorization for colon cancer based on national survival outcomes data.Preoperative staging of rectal carcinoma.Indications for and results of combined modality treatment of colorectal cancer.Perioperative radiotherapy in rectal cancer.Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial.Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent RadiochemotherapyRevised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomesFive fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer.Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists.Prospective phase II study of preoperative chemoradiation with capecitabine in locally advanced rectal cancerEfficacy of postoperative concurrent chemoradiation for resectable rectal cancer: a single institute experiencePre-operative chemoradiotherapy and total mesorectal excision surgery of rectal cancer: towards the eradication of pelvic failures?Impact of the new AJCC staging system and adjuvant treatment in rectal cancerPopulation-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age.Abdominal irradiation modulates 5-Fluorouracil pharmacokinetics.Locally recurrent rectal cancer: role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence.Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification?
P2860
Q24194802-108889C5-F7AF-4E9E-B03C-47B16A605410Q24201072-6153BDF0-27B4-4005-83E4-28B5C69D29A9Q24241723-BBA96FE7-B022-4F95-8C5D-A3305664C59AQ24241795-A525A5D0-CDA9-456A-834E-EB12E45343DEQ24641833-DEFE44EA-5F78-446D-9935-F836E3056863Q24795468-91F0B912-256F-4D36-B02A-4BEC23BBB693Q26775099-F8A8191A-42BA-4538-A631-F142D990150CQ26796352-BB4BA55F-8DC8-40B7-B76C-E7C34934E868Q27021105-9113CFAC-33A9-4971-8809-C55BEE6760B9Q28177705-283A6A49-72FB-40BE-967D-B820C120FBD9Q28280008-DB1FBE8C-8757-4F83-B72F-5DDE4189F1BAQ28362856-A2884ED6-59A9-4FC3-B583-B98A00DE1FF5Q28364849-5E549DDD-2B4C-44FF-BFAC-B58DD33FD036Q28365788-7F922E6A-CEB2-4368-93D2-29BA1EC5804EQ30300958-934C7B4D-DF3C-475E-95FB-716ABE675CDCQ30367899-9B41E5F7-E669-4937-A949-68648168223FQ30484649-2FC3B4F7-DF44-484B-86D4-FB4566D3B3EAQ30560218-C874978E-D637-48A3-ADC0-096FFBF1FD14Q31138958-82D08DFD-8879-4666-AB32-FE2E780CABA7Q31172480-B78FFE15-CA1B-4D4F-9A80-3F211464D6F6Q32160328-8B49870A-7C20-497E-B0A2-2C7B354A6119Q33485881-AA2314ED-9656-4D4A-B000-210758569059Q33516922-A928288C-681F-4944-830F-D6B83D3FE2D3Q33535189-13038102-A709-4192-99F2-68F0F9BAAE10Q33544640-98628B21-2D84-4896-A349-B19463DA599EQ33544644-CBED59DB-DC02-47A3-B803-EC73DE511D26Q33593850-F64AF26E-5078-4664-B2DE-89BC37408B38Q33619231-5D71ED4B-38C7-43C3-A652-5605D823EB82Q33627785-99B6A19A-3EB3-4D19-967B-6514FDD846C2Q33637997-EDAB122B-A890-420B-94C3-A89D854A2429Q33729092-4638C64E-2444-4EF4-8654-504849140D1FQ33742643-CB6EF04E-A685-44D1-8CB2-479F91C11E86Q33746816-9E544FE9-5DC4-4BA6-9CE1-F5296B7E1CA3Q33746878-3BDD623C-DFC8-462C-9583-625421451229Q33748946-099FB0D3-BECF-4723-A90E-5F39A9EB8768Q33791360-F2F3A0B7-31EA-43B5-9985-C287F460304BQ33799243-65A6F384-E498-4F84-B026-6634810AE2A3Q33816059-3F5A7CC4-BF4E-4B93-9A00-099BCDF3B62CQ33825336-2627F695-9A76-45E5-8F33-B62D5252B022Q33828595-9A647788-C809-4E36-99E1-9E3CCAED6D45
P2860
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
description
1991 nî lūn-bûn
@nan
1991 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մարտին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
@ast
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
@en
type
label
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
@ast
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
@en
prefLabel
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
@ast
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
@en
P2093
P1476
Effective surgical adjuvant therapy for high-risk rectal carcinoma.
@en
P2093
Collins RT
Gunderson LL
Kubista TP
Mailliard JA
Moertel CG
P304
P356
10.1056/NEJM199103143241101
P407
P577
1991-03-01T00:00:00Z